Research on the circular RNA bioinformatics in patients with acute myocardial infarction

Lianli Yin1, Yinghua Tang2, Minghe Jiang3

  • 1Department of Clinical Laboratory, Nanning Second People's Hospital, the Third Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.

Insights

Circular RNAs (circRNAs) and microRNAs interact in acute myocardial infarction (AMI) development. These circRNAs may play a role in the pathogenesis of AMI, offering potential diagnostic and therapeutic targets.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cardiovascular Research

Background:

  • Acute myocardial infarction (AMI) is a leading cause of mortality worldwide.
  • The underlying molecular mechanisms of AMI are complex and not fully understood.
  • Circular RNAs (circRNAs) are emerging as key regulators in various biological processes.

Purpose of the Study:

  • To identify circRNAs associated with acute myocardial infarction (AMI).
  • To explore the relationship between circRNAs and AMI.
  • To investigate the potential mechanisms involving circRNAs in AMI pathogenesis.

Main Methods:

  • Expression profiling of circRNAs using microarray gene chips in 3 AMI patients and 3 healthy controls.
  • Identification of differentially expressed circRNAs between AMI patients and controls.
  • Construction of a circRNA-microRNA (miRNA) regulatory network.

Main Results:

  • 650 differentially expressed circRNAs were identified in AMI patients (535 up-regulated, 115 down-regulated).
  • Key circRNAs (e.g., hsa_circ_0066439, hsa_circ_0081241, hsa_circ_0122984) were found to regulate signaling pathways via miRNAs (e.g., hsa-miR-1254, hsa-miR-328-5p).
  • Differentially expressed circRNAs are implicated in pathways such as MAPK signaling and focal adhesion, relevant to cardiovascular diseases.

Conclusions:

  • CircRNA and miRNA interactions are involved in the development of AMI.
  • CircRNAs may play a significant role in the pathogenesis of AMI.
  • CircRNAs represent potential biomarkers and therapeutic targets for AMI.
Abstract